Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1). (Q48593444)
Jump to navigation
Jump to search
scientific article published in November 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1). |
scientific article published in November 2011 |
Statements
1 reference
Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1). (English)
1 reference
1 reference
M Hoffmann
1 reference
G Wozel
1 reference
J-P Ortonne
1 reference
H Zheng
1 reference
H van Hoogstraten
1 reference
K Reich
1 reference
1 November 2011
1 reference
165
1 reference
5
1 reference
1109-1117
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference